Figure 6.

Kaplan–Meier curves showing the occurrence of safety communications after medicines’ approval depending on the time taken by the manufacturer regulatory response time.
, 0–100 days;
, 101–170 days;
, > 170 days

Kaplan–Meier curves showing the occurrence of safety communications after medicines’ approval depending on the time taken by the manufacturer regulatory response time.
, 0–100 days;
, 101–170 days;
, > 170 days